Business

CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES STRATEGIC INITIATIVE TO APPLY AI TECHNOLOGY ACROSS THE TCM SUPPLY CHAIN

TAIZHOU, China, Jan. 15, 2026 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) (“China SXT” or the “Company”), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces (“TCMPs”), including Advanced TCMPs (Directly-Oral TCMP and After-Soaking-Oral TCMP), fine TCMPs, regular TCMPs, and TCM Homologous Supplements (“TCMHS”), today announced as part of its Artificial Intelligence (AI) Insight

articleChina Sxt Pharmaceuticals, Inc.January 15, 20263/company/china-sxt-pharmaceuticals-inc/news/china-sxt-pharmaceuticals-inc-announces-140000189
CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES STRATEGIC INITIATIVE TO APPLY AI TECHNOLOGY ACROSS THE TCM SUPPLY CHAIN

About this update from China Sxt Pharmaceuticals, Inc.

[{"type":"image","alt":"China SXT Pharmaceuticals, Inc.","displaySize":"","headline":null,"caption":"China SXT Pharmaceuticals, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":143,"url":"https://media.zenfs.com/en/globenewswire.com/0752bfd017038ebb637ef431c9d6b23d"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/ZjUlwzAf_D2m66P4qQZMlw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIwMDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/0752bfd017038ebb637ef431c9d6b23d","width":300,"height":143}},"lazy":false},{"type":"text","content":"TAIZHOU, China, Jan. 15, 2026 (GLOBE NEWSWIRE) --  China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) (“China SXT” or the “Company”), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces (“TCMPs”), including Advanced TCMPs (Directly-Oral TCMP and After-Soaking-Oral TCMP), fine TCMPs, regular TCMPs, and TCM Homologous Supplements (“TCMHS”), today announced as part of its Artificial Intelligence (AI) Insight Initiative to explore the application of Artificial Intelligence (AI) and related digital technologies across the Traditional Chinese Medicine (TCM) raw-material supply chain. This initiative is part of the Company’s long-term plan to improve supply chain transparency, operational stability, and quality oversight.","length":822,"tagName":"p"},{"type":"text","content":"The Company plans to explore the use of AI-supported analytical methods in key supply chain areas such as cultivation environment monitoring, origin and authenticity assessment, quality evaluation, and material grading. China SXT also intends to examine the potential use of AI in supply-demand forecasting and circulation efficiency, with the goal of supporting more consistent and data-informed supply chain management.","length":421,"tagName":"p"},{"type":"text","content":"By enhancing digital analytics and process visibility across critical stages of the TCM raw-material supply chain, China SXT aims to strengthen traceability, reinforce quality control, and support more reliable resource planning. These efforts align with the Company’s broader strategy of applying technology to improve overall operational management while preserving the traditional principles of TCM raw-material production.","length":426,"tagName":"p"},{"typ...

More updates from China Sxt Pharmaceuticals, Inc.

Traditional Chinese Medicinesupply chainThe Companysupply chain managementpharmaceutical companyTCM Homologous SupplementsChinaCompany